{
    "2018-12-25": [
        [
            {
                "time": "",
                "original_text": "医疗保健：至暗时刻 个股有战略布局机会",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "战略布局",
                        "机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：珍惜优质公司回调的机会",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "优质公司",
                        "回调",
                        "机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗三季报跟踪:业绩增长势头强劲,双平台布局稳步推进",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "三季报",
                        "业绩增长",
                        "双平台布局"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:三季报披露期,坚守业绩主线",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "业绩主线"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:行业估值位于历史底部,可逐步配置优质个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业估值",
                        "历史底部",
                        "优质个股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "持续调整不改乐观预期，机构目光再度聚焦传统行业",
                "features": {
                    "keywords": [
                        "持续调整",
                        "乐观预期",
                        "传统行业"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "传统行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药政策陆续出台 医药板块止跌反弹",
                "features": {
                    "keywords": [
                        "医药政策",
                        "医药板块",
                        "止跌反弹"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}